FDA Inspection 1340398 — Abbvie Operations Singapore Pte Ltd

Abbvie Operations Singapore Pte Ltd — FEI 3011774256

The FDA completed an inspection of Abbvie Operations Singapore Pte Ltd on Sep 4, 2026 in Singapore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 4, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Singapore (Singapore)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.